Correlation Between Nascent Biotech and PhaseBio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nascent Biotech and PhaseBio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nascent Biotech and PhaseBio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nascent Biotech and PhaseBio Pharmaceuticals, you can compare the effects of market volatilities on Nascent Biotech and PhaseBio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nascent Biotech with a short position of PhaseBio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nascent Biotech and PhaseBio Pharmaceuticals.
Diversification Opportunities for Nascent Biotech and PhaseBio Pharmaceuticals
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Nascent and PhaseBio is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Nascent Biotech and PhaseBio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PhaseBio Pharmaceuticals and Nascent Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nascent Biotech are associated (or correlated) with PhaseBio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PhaseBio Pharmaceuticals has no effect on the direction of Nascent Biotech i.e., Nascent Biotech and PhaseBio Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nascent Biotech and PhaseBio Pharmaceuticals
Given the investment horizon of 90 days Nascent Biotech is expected to generate 64.72 times less return on investment than PhaseBio Pharmaceuticals. But when comparing it to its historical volatility, Nascent Biotech is 19.52 times less risky than PhaseBio Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. PhaseBio Pharmaceuticals is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 0.06 in PhaseBio Pharmaceuticals on August 31, 2024 and sell it today you would lose (0.03) from holding PhaseBio Pharmaceuticals or give up 50.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 8.29% |
| Values | Daily Returns |
Nascent Biotech vs. PhaseBio Pharmaceuticals
Performance |
| Timeline |
| Nascent Biotech |
| PhaseBio Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Nascent Biotech and PhaseBio Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nascent Biotech and PhaseBio Pharmaceuticals
The main advantage of trading using opposite Nascent Biotech and PhaseBio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nascent Biotech position performs unexpectedly, PhaseBio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PhaseBio Pharmaceuticals will offset losses from the drop in PhaseBio Pharmaceuticals' long position.| Nascent Biotech vs. Protokinetix | Nascent Biotech vs. Silo Pharma | Nascent Biotech vs. Vg Life Sciences | Nascent Biotech vs. Mymetics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |